Efficacy of Statin/Ezetimibe for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Akshaya Srikanth BhagavathulaWafa Ali AldhaleeiNadya Obaid Al MatrooshiJamal Rahmani

Published in: Clinical drug investigation (2020)

Our study found that statin/ezetimibe combinations reduced LDL-C, TC, and TG levels but had minimal effects on HDL-C and no effect HsCRP biomarkers in ASCVD patients. The statin/ezetimibe therapy enabled a more effective reduction in LDL-C levels; however, the duration of the treatment was suboptimal.

Keyphrases

cardiovascular disease
low density lipoprotein
end stage renal disease
coronary artery disease
newly diagnosed
ejection fraction
chronic kidney disease
systematic review
type diabetes
cardiovascular events
patient reported outcomes
cell therapy